https://www.medscape.com/viewarticle/surveillance-strategies-hepatocellular-carcinoma-new-update-2026a1000dov
Advancements in surgical, locoregional, and systemic therapies have improved outcomes for early hepatocellular carcinoma (HCC), but most cases are diagnosed at later stages owing to the limitations and underuse of current surveillance modalities.
No hay comentarios:
Publicar un comentario